We are live on ! Find out more
Capital Fund Management (CFM)

Capital Fund Management (CFM) Portfolio holdings

AUM $22.1B
1-Year Est. Return 20.49%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+20.49%
3 Year Est. Return
+61.01%
5 Year Est. Return
+50.59%
10 Year Est. Return
+196.1%
AUM
$7.23B
AUM Growth
+$685M
Cap. Flow
+$318M
Cap. Flow %
4.4%
Top 10 Hldgs %
12.49%
Holding
2,168
New
899
Increased
302
Reduced
322
Closed
639

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$93.7M
2
GS icon
Goldman Sachs
GS
+$84.3M
3
PG icon
Procter & Gamble
PG
+$83.2M
4
ABT icon
Abbott
ABT
+$58.7M
5
GE icon
GE Aerospace
GE
+$55.7M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$64.3M
2
LLY icon
Eli Lilly
LLY
+$58.5M
3
MON
Monsanto Co
MON
+$51.2M
4
T icon
AT&T
T
+$33.4M
5
AEP icon
American Electric Power
AEP
+$33.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.49%
2 Financials 7.91%
3 Technology 7.11%
4 Consumer Staples 6.01%
5 Industrials 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCS icon
1576
Barclays
BCS
$92.7B
-981,541
Closed -$14.3M
BF.B icon
1577
CALL
Brown-Forman Class B
BF.B
$13.2B
-10,625
Closed -$230K
BGS icon
1578
B&G Foods
BGS
$287M
-99,399
Closed -$3.38M
BHE icon
1579
Benchmark Electronics
BHE
$2.87B
-14,690
Closed -$295K
BIIB icon
1580
Biogen
BIIB
$30B
-97,336
Closed -$21.8M
BMO icon
1581
Bank of Montreal
BMO
$126B
-38,138
Closed -$2.21M
BMRN icon
1582
BioMarin Pharmaceuticals
BMRN
$11.6B
-24,264
Closed -$1.61M
BN icon
1583
Brookfield
BN
$104B
-245,475
Closed -$2.07M
BNS icon
1584
Scotiabank
BNS
$107B
-25,694
Closed -$1.28M
BPOP icon
1585
PUT
Popular Inc
BPOP
$11.2B
-7,400
Closed -$224K
BRFS
1586
DELISTED
BRF SA
BRFS
-463,483
Closed -$10.1M
BRKR icon
1587
Bruker
BRKR
$9.57B
-14,358
Closed -$232K
BTE icon
1588
Baytex Energy
BTE
$3.25B
-32,853
Closed -$1.18M
BTI icon
1589
British American Tobacco
BTI
$131B
-16,866
Closed -$868K
BUD icon
1590
AB InBev
BUD
$170B
-242,800
Closed -$23.1M
BWA icon
1591
BorgWarner
BWA
$13.1B
-53,153
Closed -$2.02M
CADE
1592
DELISTED
Cadence Bank
CADE
-24,750
Closed -$438K
CASY icon
1593
Casey's General Stores
CASY
$32.2B
-26,727
Closed -$1.61M
CATO icon
1594
Cato Corp
CATO
$68.3M
-13,500
Closed -$337K
CATY icon
1595
Cathay General Bancorp
CATY
$4.22B
-22,671
Closed -$461K
CCEP icon
1596
Coca-Cola Europacific Partners
CCEP
$48.3B
-364,005
Closed -$12.8M
CCI icon
1597
Crown Castle
CCI
$33.3B
-210,845
Closed -$15.3M
CCL icon
1598
Carnival Corporation Ltd
CCL
$38.1B
-342,569
Closed -$11.7M
CE icon
1599
Celanese
CE
$4.9B
-266,451
Closed -$11.9M
CENX icon
1600
CALL
Century Aluminum
CENX
$4.43B
-22,600
Closed -$210K

Similar funds

Capital Fund Management (CFM)'s Q3 2013 Portfolio in Review

As of Q3 2013, Capital Fund Management (CFM) held 2,168 positions worth $7.23B, up 10% from $6.55B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Fund Management (CFM) deployed $318M of net new capital in Q3 2013, opening 899 new positions and adding to 302 existing holdings. Its largest new stake was Alphabet (Google) Class C: 4,238,026 shares worth $92.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, up from 6.4% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Eli Lilly, an estimated $58.5M trimmed.

  • Capital Fund Management (CFM)'s largest Q3 2013 buy was Alphabet (Google) Class C: 4,238,026 shares worth $92.5M.
  • Capital Fund Management (CFM) added most to Abbott in Q3 2013, an estimated $58.7M increase.
  • Capital Fund Management (CFM)'s biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $58.5M.
  • Capital Fund Management (CFM) fully exited Walmart Inc in Q3 2013, selling an estimated $64.3M.
  • Capital Fund Management (CFM)'s ten largest holdings make up 12% of its $7.23B portfolio in Q3 2013.
  • Capital Fund Management (CFM) opened 899 new positions and closed 639 in Q3 2013.
  • Capital Fund Management (CFM)'s portfolio value rose 10% quarter-over-quarter to $7.23B.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2013, filed 31 Oct 2013.